MBHB Partner Kevin Noonan shares insights into the FTC’s investigation of Teva’s patents

Teva Pharmaceutical has refused to remove dozens of patents following the FTC’s warnings. In STAT news, MBHB Partner Kevin Noonan shares his thoughts. View the article.